- 4H-Carbazol-4-one, 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl)methyl)-
- 4H-Carbazol-4-one,1,2,3,9-tetrahydro-6-methoxy-
- 116006-97-41,2-Benzenediamine-15N2
- 116008-90-32-Butene-1,1,1-d3 (6CI)
- 1160112-78-62H-Pyrrolo[2,3-b]pyridin-2-one, 1,3-dihydro-5-iodo-
- 1160221-26-03-(6-{[1-(2,2-Difluoro-benzo[1,3]dioxol-5-yl)-cyclopropanecarbonyl]-amino}-3-methyl-pyridin-2-yl)-benzoic acid hydrochloride
- 1160246-85-42-Phenyl-2,6-diazaspiro[3.3]heptan-1-one
- 1160247-15-3tert-butyl 2-(aminomethyl)-7-azaspiro[3.5]nonane-7-carboxylate
- 1160247-92-6VU 0238429
- 116026-80-32-Pyridinecarboxaldehyde,O-ethyloxime, (Z)- (9CI)
- 116026-93-8Carbamic acid,N-(3-formyl-4-pyridinyl)-, 1,1-dimethylethyl ester
- 116026-94-9Carbamic acid,N-(3-formyl-2-pyridinyl)-, 1,1-dimethylethyl ester
Hot Products
- 104987-11-3Tacrolimus
- 141-53-7Sodium formate
- 8001-54-5Quaternary ammonium compounds, alkylbenzyldimethyl, chlorides
- 9003-39-8Povidone
- 10161-34-9Trenbolone acetate
- 402957-28-2Telaprevir
- 68-19-9Cyanocobalamin
- 7631-86-9Silicon dioxide
- 302-79-4Tretinoin
- 77-92-9Citric acid
|
Basic Information |
|
Post buying leads |
|
Suppliers |
|
Cas Database |
| Name |
4H-Carbazol-4-one, 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl)methyl)- |
EINECS | 1308068-626-2 |
| CAS No. | 116002-70-1 | Density | N/A |
| PSA | 39.82000 | LogP | 3.12850 |
| Solubility | N/A | Melting Point |
N/A |
| Formula | C18H19N3O | Boiling Point | N/A |
| Molecular Weight | 293.368 | Flash Point | N/A |
| Transport Information | N/A | Appearance | N/A |
| Safety | Risk Codes | N/A | |
| Molecular Structure |
|
Hazard Symbols | N/A |
| Synonyms |
9-METHYL-3-[(2-METHYLIMIDAZOL-1-YL)METHYL]-2,3-DIHYDRO-1H-CARBAZOL-4-ONE; |
Article Data | 30 |
4H-Carbazol-4-one, 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl)methyl)- Chemical Properties
Molecular Structure of 4H-Carbazol-4-one, 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl)methyl)- (CAS NO.99614-02-5):
.png)
Molecular Formula: C18H19N3O
Molecular Weight: 293.363
IUPAC Name: 9-Methyl-3-[(2-methylimidazol-1-yl)methyl]-2,3-dihydro-1H-carbazol-4-one
Synonyms of 4H-Carbazol-4-one, 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl)methyl)- (CAS NO.99614-02-5): Ondansetron [USAN:INN:BAN] ; (RS)-1,2,3,9-Tetrahydro-9-methyl-3-(2-methylimidazol-1-ylmethyl)carbazol-4-one ; 1,2,3,9-Tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl)methyl)-4H-carbazol-4-one ; BRN 3622981 ; GR 38032 ; GR 38032X ; Odansetron [common misspelling of ondansetron] ; UNII-4AF302ESOS ; Zofran ; Zofran ODT ; Zophren ; Zudan
CAS NO: 99614-02-5
Classification Code: Anti-anxiety agents ; Antiemetics ; Antipruritics ; Antipsychotic agents ; Autonomic Agents ; Central Nervous System Agents ; Central Nervous System Depressants ; Dermatologic Agents ; Drug / Therapeutic Agent ; Gastrointestinal Agents ; Human Data ; Neurotransmitter Agents ; Peripheral Nervous System Agents ; Psychotropic Drugs ; Serotonin Agents ; Serotonin antagonists ; Tranquilizing Agents
Index of Refraction: 1.677
Molar Refractivity: 86.75 cm3
Molar Volume: 230.1 cm3
Surface Tension: 48.9 dyne/cm
Density: 1.27 g/cm3
Flash Point: 284 °C
Enthalpy of Vaporization: 82.5 kJ/mol
Boiling Point: 546 °C at 760 mmHg
Vapour Pressure of 4H-Carbazol-4-one, 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl)methyl)- (CAS NO.99614-02-5): 5.62E-12 mmHg at 25°C
4H-Carbazol-4-one, 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl)methyl)- Toxicity Data With Reference
| Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
|---|---|---|---|---|---|
| dog | LD | intravenous | > 10mg/kg (10mg/kg) | Seminars in Oncology. Vol. 19(Suppl, | |
| man | TDLo | intravenous | 229ug/kg/I (0.229mg/kg) | LIVER: "JAUNDICE, OTHER OR UNCLASSIFIED" | Lancet. Vol. 344, Pg. 190, 1994. |
| mouse | LD | intraperitoneal | > 5mg/kg (5mg/kg) | Arzneimittel-Forschung. Drug Research. Vol. 46, Pg. 401, 1996. | |
| mouse | LD | oral | > 10mg/kg (10mg/kg) | Arzneimittel-Forschung. Drug Research. Vol. 46, Pg. 401, 1996. | |
| mouse | LDLo | intravenous | 2500ug/kg (2.5mg/kg) | Seminars in Oncology. Vol. 19(Suppl, | |
| rat | LDLo | intravenous | 20mg/kg (20mg/kg) | Seminars in Oncology. Vol. 19(Suppl, |
What can I do for you?
Get Best Price
